Workflow
Veracyte(VCYT) - 2022 Q3 - Earnings Call Presentation

Q3 2022 Business and Financial Presentation November 2, 2022 11/2/2022 © Veracyte, Inc. All rights reserved. 1 Forward-looking statements This presentation contains forward-looking statements, including, but not limited to, our statements related to our expected total revenue and other financial and operating results for 2022 and our plans, objectives, expectations (financial and otherwise) or intentions with respect to our Prosigna, Afirma, Percepta, Envisia, LymphMark, Decipher Prostate, Percepta Nasal Sw ...